Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00448617 · ClinicalTrials.gov registry record

Cigarette Smoke and Susceptibility to Influenza Infection

A clinical trial of Healthy, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
138
Enrollment target
1
Study location

NCT00448617 is a study of Healthy that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 138 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00448617, a study of Healthy, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
138 participants
Enrollment target
1
Study location

Study Summary

This study will be a descriptive comparison of the effects of live attenuated influenza virus (FluMist) on nasal inflammation and oxidative stress in healthy young adults who are not exposed to smoke vs smokers. It is hypothesized that passive exposure to second-hand smoke (SHS) results in increased susceptibility to the effects of influenza virus in nasal epithelium in humans and that these effects are mediated by SHS-induced oxidative stress

Conditions Studied

Study Locations (1)

North Carolina

  • UNC Center for Environmental Medicine, Asthma and Lung Biology - Chapel Hill

Trial Details

FieldValue
Enrollment Target 138 participants
Start Date 2006-07
Est. Completion 2011-09

What the Registry Record Tells You About NCT00448617

The ClinicalTrials.gov registry entry for NCT00448617 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 138 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (79% lower). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 0 interventions.

NCT00448617 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT00448617 about?

NCT00448617 is a clinical study titled "Cigarette Smoke and Susceptibility to Influenza Infection". This study will be a descriptive comparison of the effects of live attenuated influenza virus (FluMist) on nasal inflammation and oxidative stress in healthy young adults who are not exposed to smoke vs smokers. It is hypothesized that passive exposure to second-hand smoke (SHS) results in increased...

What is the current status of trial NCT00448617?

This trial is currently completed. The enrollment target is 138 participants. The study started on 2006-07. Estimated completion is 2011-09.

What conditions does trial NCT00448617 study?

This clinical trial studies the following conditions: Healthy.

Who is sponsoring clinical trial NCT00448617?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00448617 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.